Orchestra BioMed (OBIO) Revenue & Revenue Breakdown
Orchestra BioMed Revenue Highlights
Latest Revenue (Y)
$2.76M
Latest Revenue (Q)
$778.00K
Main Segment (Y)
Product
Orchestra BioMed Revenue by Period
Orchestra BioMed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.76M | -21.88% |
| 2022-12-31 | $3.53M | -551.79% |
| 2021-12-31 | $-782.00K | -113.71% |
| 2020-12-31 | $5.70M | - |
Orchestra BioMed generated $2.76M in revenue during NA 2023, up -21.88% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Orchestra BioMed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $778.00K | 25.48% |
| 2024-03-31 | $620.00K | 136.64% |
| 2023-12-31 | $262.00K | -37.47% |
| 2023-09-30 | $419.00K | -54.21% |
| 2023-06-30 | $915.00K | -21.39% |
| 2023-03-31 | $1.16M | 5.53% |
| 2022-12-31 | $1.10M | -5.16% |
| 2022-09-30 | $1.16M | 190.02% |
| 2022-06-30 | $401.00K | -53.70% |
| 2022-03-31 | $866.00K | -135.30% |
| 2021-12-31 | $-2.45M | -284.02% |
| 2021-09-30 | $1.33M | -236.30% |
| 2021-06-30 | $-978.00K | -174.32% |
| 2021-03-31 | $1.32M | - |
Orchestra BioMed generated $778.00K in revenue during Q2 2024, up 25.48% compared to the previous quarter, and up 66.84% compared to the same period a year ago.
Orchestra BioMed Revenue Breakdown
Orchestra BioMed Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 |
|---|---|
| Product | $654.00K |
Orchestra BioMed's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 |
|---|---|
| Product | $123.00K |
Orchestra BioMed's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).
OBIO Revenue FAQ
What is Orchestra BioMed’s yearly revenue?
Orchestra BioMed's yearly revenue for 2023 was $2.76M, representing a decrease of -21.88% compared to 2022. The company's yearly revenue for 2022 was $3.53M, representing a decrease of -551.79% compared to 2021. OBIO's yearly revenue for 2021 was $-782K, representing a decrease of -113.71% compared to 2020.
What is Orchestra BioMed’s quarterly revenue?
Orchestra BioMed's quarterly revenue for Q2 2024 was $778K, a 25.48% increase from the previous quarter (Q1 2024), and a -14.97% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $620K, a 136.64% increase from the previous quarter (Q4 2023), and a -46.74% decrease year-over-year (Q1 2023). OBIO's quarterly revenue for Q4 2023 was $262K, a -37.47% decrease from the previous quarter (Q3 2023), and a -76.25% decrease year-over-year (Q4 2022).
What is Orchestra BioMed’s revenue growth rate?
Orchestra BioMed's revenue growth rate for the last 3 years (2021-2023) was -452.94%
What are Orchestra BioMed’s revenue streams?
Orchestra BioMed's revenue streams in c 23 are Product
What is Orchestra BioMed’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Orchestra BioMed was Product. This segment made a revenue of $654K, representing 100.00% of the company's total revenue.